Highland Capital Management, LLC Vertex Pharmaceuticals Inc Transaction History

Highland Capital Management, LLC

$1.73 Billion
Q3 2024

A detailed history of Highland Capital Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Highland Capital Management, LLC holds 6,236 shares of VRTX stock, worth $2.9 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

6,236

Previous 6,475 3.69%

Holding current value

$2.9 Million

Previous $3.03 Million 4.42%

% of portfolio

0.17%

Previous 0.18%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$460.0 - $505.78 $109,940 - $120,881	-239 Reduced 3.69%	6,236 $2.9 Million
Q2 2024 Jul 25, 2024	SELL	$392.81 - $485.53 $493,369 - $609,825	-1,256 Reduced 16.25%	6,475 $3.03 Million
Q1 2024 May 07, 2024	BUY	$407.69 - $446.08 $14,269 - $15,612	35 Added 0.45%	7,731 $3.23 Million
Q4 2023 Jan 17, 2024	SELL	$343.0 - $410.68 $8,575 - $10,267	-25 Reduced 0.32%	7,696 $3.13 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $37,876 - $40,595	-112 Reduced 1.43%	7,721 $2.68 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $18,236 - $20,410	-58 Reduced 0.74%	7,833 $2.76 Million
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $2.23 Million - $2.55 Million	7,891 New	7,891 $2.49 Million
Q4 2022 Feb 07, 2023	SELL	$285.76 - $321.48 $19,431 - $21,860	-68 Reduced 0.83%	8,076 $2.33 Million
Q3 2022 Nov 09, 2022	BUY	$273.83 - $305.53 $2,738 - $3,055	10 Added 0.12%	8,144 $2.36 Million
Q1 2022 Apr 19, 2022	BUY	$221.42 - $260.97 $11,956 - $14,092	54 Added 0.67%	8,134 $2.12 Million
Q4 2021 Jan 28, 2022	SELL	$177.01 - $223.45 $354 - $446	-2 Reduced 0.02%	8,080 $1.77 Million
Q3 2021 Oct 25, 2021	SELL	$181.39 - $202.99 $155,632 - $174,165	-858 Reduced 9.6%	8,082 $1.47 Million
Q2 2021 Jul 30, 2021	SELL	$187.49 - $221.1 $51,747 - $61,023	-276 Reduced 2.99%	8,940 $1.8 Million
Q1 2021 Apr 27, 2021	SELL	$207.02 - $241.31 $160,854 - $187,497	-777 Reduced 7.78%	9,216 $1.98 Million
Q4 2020 Jan 21, 2021	SELL	$207.01 - $276.09 $91,705 - $122,307	-443 Reduced 4.24%	9,993 $2.36 Million
Q3 2020 Oct 16, 2020	BUY	$255.65 - $303.1 $34,768 - $41,221	136 Added 1.32%	10,436 $2.84 Million
Q2 2020 Jul 22, 2020	BUY	$225.48 - $295.8 $206,990 - $271,544	918 Added 9.78%	10,300 $2.99 Million
Q1 2020 May 05, 2020	BUY	$199.77 - $247.81 $1.87 Million - $2.32 Million	9,382 New	9,382 $2.23 Million
Q3 2018 Oct 17, 2018	SELL	$167.73 - $192.74 $536,400 - $616,382	-3,198 Closed	0 $0
Q2 2018 Jul 18, 2018	SELL	$145.72 - $169.96 $6,411 - $7,478	-44 Reduced 1.36%	3,198 $544,000
Q1 2018 Apr 16, 2018	BUY	$151.6 - $177.13 $69,736 - $81,479	460 Added 16.53%	3,242 $528,000
Q4 2017 Jan 26, 2018	BUY	$137.28 - $155.55 $15,924 - $18,043	116 Added 4.35%	2,782 $417,000
Q3 2017 Oct 10, 2017	BUY	$148.13 - $162.24 $394,914 - $432,531	2,666	2,666 $405,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management, LLC with notifications on news.

Account

Highland Capital Management, LLC Vertex Pharmaceuticals Inc Transaction History